Serum eosinopholic cationic protein (ECP) in asthmatic Malaysian children by Chan, P.W.K. et al.
ORIGINAL ARTICLE
Serum Eosinophilic Cationic Protein (ECP)
Asthmatic Malaysian Children
•In
P W K Chan, MRCP*, H H Samsinah, PhD**, H Z Arpin, BPharm**, A M Mustafa, PhD**, J A
de Bruyne, MRCP**
*Division of Respiratory Medicine, Department of Paediatrics, **Department of Pharmacy and Pharmacology,
University Malaya Medical Center, 50603 Kuala Lumpur
Introduction
The understanding of the pathophysiologic
processes that result in bronchial asthma have led
to the recognition of the many cellular and
immuno-chemical components that are pivotal in
the inflammatory cascade of this disorder.
Eosinophil infiltration and activation in the
airways is an important aspect of childhood
asthma. Its activation is associated with the
release of granule-derived proteins, the most
cytotoxic being eosinophilic cationic protein
(ECP) and major basic protein \ both of which
have been demonstrated to cause airway damage.
Blood measurements of ECP can be done using a
commercially available assay and may be used as
a tool to reflect eosinophil activation in the lung.
Nonetheless, its relevance and usefulness in a
tropical environment and where eosinophilic
activation may be due to previous worm
infestation are less well documented. We
therefore set out to evaluate serum ECP in 20
asthmatic Malaysian children compared to non-
asthmatic healthy controls.
Materials and Methods
We recruited 20 children attending the Paediatric
Asthma Clinic who had an established diagnosis
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of moderate to severe bronchial asthma and were
receiving inhaled prophylaxis. Asthmatic children
who received a course of oral corticosteroids in
the preceding 4 weeks were excluded. Nineteen
non-asthmatic healthy controls were recruited
from children admitted for elective surgical
procedures. Non-asthmatic healthy controls were
excluded if they had any history of allergic
rhinitis, food allergy or atopic eczema. All these
children were aged between 5 and 15 years and
did not have any previous history of an
immunodeficiency disorder. Ethics committee
approval was obtained for the study and parental
informed consent was given before inclusion into
the study. Each parent was interviewed
individually to determine the socio-demographic
profile and passive smoke exposure prior to
collection of blood samples for serum ECP and
urine cotinine levels. A peak expiratory flow rate
(PEFR) was also performed 3 times for each
subject and the best was taken into account at the
time of recruitment.
Data collected was analyzed with SPSS version 7.0
(SPSS Inc.,Chicago, IL, USA) using Windows 1998
operating system. Quantitative data was
compared using the Mann-Whitney U non-
parametric test and the student's t test where
appropriate. Dichotomous variables were
compared using the Fishers exact test. A p value
of less than 0.05 was considered significant.
Measurement of serum ECP
Blood samples for the determination of serum
ECP were collected by drawing venous blood and
transferring 2 ml directly into a 25ml silicone-
containing glass tube (Hemogard SST® tube;
Becton Dicksinson Vacutainer Systems). The
blood was then allowed to clot at 20 - 24° C for
90 minutes after which it was centrifuged at 1300
G for 10 minutes. The resultant serum was then
collected and stored at -20° C till analysis. The
serum concentrations of ECP were measured with
a commercially available fluoro-imrnunoassay in
accordance with the manufacturer's guide and
instructions (ImmunoCAP ECP kit; Pharmacia CAP
Diagnostics AB, Uppsala, Sweden).
Table I: Socio-demography profile of 20 asthmatic children and 19 non-asthmatic controls
Clinical Parameter Asthmatic children Non-asthmatic controls p value
(n=20) (n= 19)
Median age (years) 10.0 12.0 0.23*
(IQ 1 6.3, IQ3 14.0) (IQ1 10.0, IQ3 14.0)
Sex
Boys 10 (50%) 6 (32%) 0.24
Girls 10 (50%) 13. (78%)
Family history of asthma 11 (55%) 8 (42%) 0.25
Either parent smokes 9 (45%) 6 (37%) 0.85
Median urinary 1.1 0.7 0.08*
cotinine levels (ng/ml) (IQ1 0.7, IQ3 2.7) (IQ1 0.0, IQ3 1.2)
*Mann-Whitney U non-parametric test
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importantly, the test is a non-invasive
measurement and can be readily done with
commercially available kits with several useful
clinical applications.
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The diagnosis of asthma in children may not
always be simple due its heterogenous
presentation, as some children may have
persistent but non-specific respiratory symptoms.
In addition, very young children cannot perform
the necessary pulmonary function tests required
for the diagnosis. Situations like these make
commitment to regular long term inhaled anti-
inflammatory therapy solely on clinical suspicion
difficult and illustrate the importance of having
available tools like serum ECP to support a
suspected diagnosis of childhood asthma.
Figure I: Serum ECP in 20 asthmatic children
and 19 non-asthmatic controls
The median serum ECP in asthmatic children was
27.0 mcglL (IQ1 8.8, IQ3 59.0); which was higher
than in the non-asthmatic controls [5.9 mcglL
(IQ1 3.0, IQ3 11.9), P = 0.002] [Figure IJ.
Five children who had a PEFR of less than 70% of
their usual best showed a higher serum ECP than
those with better PEFR (45.5 ± 22.8 vs 34.6 ± 31.0
mcglL, p = 0.523) but this difference failed to
reach statistical significance.
Discussion
An elevated serum ECP as a reflection of
eosinophil activation in bronchial asthma is a
fairly consistent finding 2, 3 and provides a
potential tool or marker for this disease, More
Disease severity and symptomatology in asthma is
determined by airway inflammation; for which
treatment strategies adopted are directed towards
reducing these inflammatory processes. Asthma
symptoms and pulmonary function tests in
children who can comply, presently guide
managing airway inflammation and adjusting
treatment in childhood asthma. Although these
clinical parameters are important, they indirectly
reflect airway inflammation; therefore normal
lung function and symptom free asthma does not
necessarily indicate that there is no ongoing
airway inflammation. The measurements of
immuno-chemical mediators like serum ECP have
been shown to reflect disease severity and
ongoing airway inflammation in asthmatic
children 4. Our study subjects with PEFR of less
that 70% had a tendency to have higher serum
ECP levels also illustrates this relationship;
however this observation failed to reach statistical
significance possibly due to the small sample size.
Serial monitoring of serum ECP may therefore
provide a potentially important adjunct in
optimizing and tailoring treatment in asthmatic
children. rthas been shown that using an elevated
serum ECP of > 20 mcglL as an indication of
increasing the corticosteroid dose in asthma
management improved pulmonary function,
decreased acute exacerbations and improved
Non·lll!\thmahc
con1rol~
Asthn".atic
children
Results
There was no significant difference in the socio-
demographic profile, family history of bronchial
asthma, passive smoke exposure and urinary
cotinine levels between the asthmatic children
recruited and the non-asthmatic controls [Table I].
Med J Malaysia Vol 57 No 2 June 2002 203
ORIGINAL ARTICLE
asthmatic well-being scores in adults 5. These
improvements were also associated with a falling
trend in the serial serum ECP measurement.
An elevated serum ECP can be used as supportive
evidence in the diagnosis of bronchial asthma in
Malaysian children. As the cost of serum ECP
studies is prohibitive, routine serum ECP
measurement in childhood asthma cannot be
advocated and should be reserved for the poorly
defined cases with persistent but less specific
respiratory symptoms. Its serial use to monitor
airway inflammation and guide childhood asthma
management will require further evaluation.
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